Free Trial

ReposiTrak (NYSE:TRAK) CEO Randall Fields Sells 3,140 Shares

ReposiTrak logo with Computer and Technology background

Key Points

  • ReposiTrak CEO Randall Fields sold 3,140 shares of the company at an average price of $14.57, totaling $45,749.80, resulting in a 6.28% decrease in his ownership.
  • Shares of ReposiTrak traded down to $14.29 with a market capitalization of $261.28 million and a reported twelve-month high of $25.01.
  • Wall Street analysts have recently downgraded ReposiTrak's stock rating, with the average rating now being a "hold" after recent reports.
  • MarketBeat previews top five stocks to own in November.

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall Fields sold 3,140 shares of ReposiTrak stock in a transaction dated Tuesday, October 14th. The shares were sold at an average price of $14.57, for a total value of $45,749.80. Following the completion of the sale, the chief executive officer directly owned 46,860 shares in the company, valued at $682,750.20. This represents a 6.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

ReposiTrak Price Performance

Shares of TRAK traded down $0.01 during midday trading on Thursday, hitting $14.29. The stock had a trading volume of 66,088 shares, compared to its average volume of 53,378. The firm has a 50 day moving average of $16.25. ReposiTrak Inc. has a twelve month low of $13.86 and a twelve month high of $25.01. The firm has a market capitalization of $261.28 million, a price-to-earnings ratio of 40.83 and a beta of 0.44. The company has a current ratio of 6.09, a quick ratio of 6.09 and a debt-to-equity ratio of 0.01.

ReposiTrak (NYSE:TRAK - Get Free Report) last released its quarterly earnings results on Monday, September 29th. The company reported $0.09 earnings per share (EPS) for the quarter. ReposiTrak had a return on equity of 14.25% and a net margin of 30.55%.The firm had revenue of $5.76 million for the quarter.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on TRAK. Wall Street Zen downgraded ReposiTrak from a "buy" rating to a "hold" rating in a research report on Friday, October 3rd. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of ReposiTrak in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Hold".

View Our Latest Report on ReposiTrak

Institutional Investors Weigh In On ReposiTrak

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Handelsbanken Fonder AB lifted its stake in shares of ReposiTrak by 7.1% in the 2nd quarter. Handelsbanken Fonder AB now owns 1,654,348 shares of the company's stock valued at $32,508,000 after acquiring an additional 110,000 shares during the last quarter. Ashford Capital Management Inc. raised its position in ReposiTrak by 93.7% during the 2nd quarter. Ashford Capital Management Inc. now owns 792,154 shares of the company's stock worth $15,566,000 after purchasing an additional 383,283 shares during the last quarter. Ingalls & Snyder LLC grew its holdings in ReposiTrak by 1.3% during the 2nd quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company's stock worth $3,905,000 after acquiring an additional 2,554 shares during the period. Los Angeles Capital Management LLC acquired a new stake in ReposiTrak during the 2nd quarter worth about $818,000. Finally, Jane Street Group LLC acquired a new stake in ReposiTrak during the 2nd quarter worth about $802,000. 27.35% of the stock is currently owned by institutional investors.

About ReposiTrak

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Featured Articles

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ReposiTrak Right Now?

Before you consider ReposiTrak, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.

While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.